These data suggest that mGluR1-expressing cancer cells could use cytokine production to regulate immune surveillance and immune cell infiltration to allow tumor cells to evade immune detection via the modulation of mGluR1 intra-tumoral signaling, i.e., prevent immune cells from eliciting an anti-tumor immune response (Table 1). The gene discussed is GRM1; the disease is neoplasm.